[Medical Fees] Survey Item Drafts for FY2028 Fee Revision Approved by Central Social Insurance Medical Council Subcommittee – Health Policy Information Center

News Highlights

Draft survey items for the FY2028 medical fee revision have been approved by the Central Social Insurance Medical Council subcommittee. As medical fee revisions significantly impact the management of medical institutions, the importance of mid-to-long-term management and succession strategies, considering the revision cycle, is increasing. Furthermore, group participation leveraging economies of scale and utilizing tax incentives through conversion to specific medical corporations or social medical corporations can also be considered for future business succession and M&A.

M&A Medical Editorial Department’s Perspective

The approval of draft survey items for the FY2028 medical fee revision is more than just a precursor to system changes. Particularly for small and medium-sized medical institutions supporting regional healthcare, the direction of the revision can be a matter of life and death for business continuity. For example, if items such as clarifying outpatient functions, utilizing ICT, and promoting home healthcare are materialized, facility investments and human resource development to respond to them will become indispensable. To distribute such investment burdens and maintain/improve facility standards, participation in medical corporation groups or M&A such as business integration are extremely effective options. In particular, organizational restructuring with a view to transitioning to a social medical corporation holds the potential to achieve both tax benefits and strengthening of the business base, requiring strategic consideration at an early stage.

Points Raised by This News

• Survey items for the FY2028 revision are being specified, impacting medical institutions’ management strategies
• Importance of maintaining facility standards and distributing facility investment burdens through economies of scale
• Possibility of utilizing tax incentives through conversion to specific medical corporations and social medical corporations
• Necessity of mid-to-long-term management and succession strategies considering the revision cycle

Practical Questions Arising from This News

• For the current draft survey items, which medical departments or functions are likely to be particularly focused on for review?
• In what specific schemes can tax benefits from group participation or corporate conversion be enjoyed?
• Looking ahead to future revisions, what management indicators should be prepared and strengthened starting now?

If You Feel “Should I Consult Too?”

The FY2028 medical fee revision may have a direct impact on your institution’s management base. While closely monitoring the trends of the revision, we recommend consulting with experts early on to consider options such as M&A or group formation as future facility investments, human resource acquisition, and business succession. In particular, consideration of corporate forms that maximize tax benefits requires specialized knowledge.

M&A Medical (CentralMedience Inc.) supports business succession for medical corporations, hospitals, and clinics with a full success-fee basis as a business succession support institution certified by the Small and Medium Enterprise Agency. We accept consultations with strict confidentiality. Free consultation here